Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

NCT02097056 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Donepezil HCL

Sponsor

Eisai Korea Inc.